Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Glucagon receptor | ||
Ligand | BDBM50199494 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_441038 (CHEMBL890125) | ||
IC50 | 3380±n/a nM | ||
Citation | Liang, R; Abrardo, L; Brady, EJ; Candelore, MR; Ding, V; Saperstein, R; Tota, LM; Wright, M; Mock, S; Tamvakopolous, C; Tong, S; Zheng, S; Zhang, BB; Tata, JR; Parmee, ER Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptor. Bioorg Med Chem Lett17:587-92 (2007) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Glucagon receptor | |||
Name: | Glucagon receptor | ||
Synonyms: | GCGR | GL-R | GLR_HUMAN | Glucagon Receptor (GCGR) | Glucagon receptor (GlucR) | ||
Type: | Enzyme | ||
Mol. Mass.: | 54026.92 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P47871 | ||
Residue: | 477 | ||
Sequence: |
| ||
BDBM50199494 | |||
n/a | |||
Name | BDBM50199494 | ||
Synonyms: | 3-(1-(1-(cis-4-tert-butylcyclohexyl)-3-(4-(trifluoromethoxy)phenyl)ureido)-2,3-dihydro-1H-indene-5-carboxamido)propanoic acid | CHEMBL398180 | ||
Type | Small organic molecule | ||
Emp. Form. | C31H38F3N3O5 | ||
Mol. Mass. | 589.6457 | ||
SMILES | CC(C)(C)[C@@H]1CC[C@@H](CC1)N(C1CCc2cc(ccc12)C(=O)NCCC(O)=O)C(=O)Nc1ccc(OC(F)(F)F)cc1 |w:11.11,wD:4.3,7.10,(-1.63,-20.96,;-1.62,-19.43,;-.08,-19.43,;-3.16,-19.42,;-1.61,-17.89,;-2.94,-17.11,;-2.94,-15.58,;-1.59,-14.81,;-.27,-15.57,;-.28,-17.12,;-1.59,-13.27,;-.26,-12.5,;.06,-11,;1.92,-11.03,;2.39,-12.49,;3.73,-13.25,;3.73,-14.8,;2.4,-15.57,;1.07,-14.8,;1.07,-13.27,;5.07,-15.57,;5.07,-17.11,;6.4,-14.8,;7.74,-15.56,;9.07,-14.79,;10.4,-15.56,;11.74,-14.78,;10.41,-17.1,;-2.93,-12.5,;-2.93,-10.96,;-4.26,-13.27,;-5.6,-12.5,;-6.94,-13.28,;-8.27,-12.5,;-8.27,-10.96,;-9.6,-10.19,;-9.6,-8.65,;-9.62,-7.11,;-8.06,-8.64,;-11.14,-8.66,;-6.94,-10.19,;-5.6,-10.95,)| | ||
Structure |